Apollo Hospitals are Combat Ready for COVID Vaccination

India: Apollo hospitals are battle ready to launch themselves into biggest impending vaccination war against COVID 19. This was virtually announced today by group Executive Vice-Chairperson Ms. Shobana Kamineni, claiming it has ability to administer 1 mill[on COVID-19 vaccines a day and has already secured cold chain to manage the safety of 300 million doses per annum.

Apollo Hospitals group announced that it is fully prepared to support the Government’s valiant battle against COVID-19. The group will leverage its robust pan India web of 19 medicine supply hubs with cold chain facilities and use its 70 hospitals, 400+ clinics, 500 corporate health centres, and 4000 pharmacies alongside their omni-channel digital platform Apollo 24|7 to ensure massive administration capacity of COVID-19 vaccines.

About 30 per cent of India is roughly 30 minutes away from an Apollo pharmacy, which can then guarantee safe and widespread reach of the vaccine, if required. More than ten thousand Apollo employees are undergoing required training and will be stationed at Apollo centres to administer the vaccine.

Ms. Shobana Kamineni, Executive Vice-Chairperson, The Apollo Group of Hospitals said, ‘As the entire country awaits a vaccine for the deadly infectious disease, one of the major challenges will be around safe and orderly delivery of doses, for the population of 1.3 billion Indians, especially the vulnerable. We are happy to share that, Apollo Hospitals have been, strengthening its vaccine cold chain for supply and gearing up all Apollo facilities for efficient and fast administration with the highest safety standards, for upto 1 million doses per day. As   the largest and most trusted integrated healthcare network in the country, we believe that it is our duty and responsibility to actively participate in the nation’s fight against COVID-19 and make India safe and healthy. Till date we have tested over 2,50,000 and have treated over 75,000 patients. Going forward it will be our privilege to work with all governments, governmental agencies and healthcare networks to ensure that a large number of people get the vaccine, quickly and safely as it becomes available. We are proud that Indian manufacturers will make most of the world’s supply of vaccine, and as healthcare service providers we will ensure the safest and most comprehensive delivery.’

Technology will play a large role in ensuring that all citizens have access to the vaccine and how it will be administered and prioritized, Apollo Hospitals was among the first healthcare providers to start working with the National Digital Health Mission.Additionally, Apollo 24|7 will host a dedicated platform for all the information related to the COVID-19 vaccine (http://bit.ly/CovidVaccineTracker). Users will be able to register themselves on Apollo 24|7 and keep them abreast with the latest update around vaccine development. The platform with the NDHM effort. Through the portal, users will be receiving constant updates about the vaccines.

  • Related Posts

    Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

    Association of Indian Medical Device Industry (AiMeD) sends SOS to Union Minister Piyush Goel New Delhi: The war tremors have started shaking the domestic medical device industry perched on the…

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

    Dr D S Rana, Chairman, Sir Ganga Ram Trust Society was Cynosure of all Eyes New Delhi: Inaugural Conference of Critical Nephrology Society of India CNSICON 26 under the aegis…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory